BIOEX — Bioextrax AB publ Balance Sheet
0.000.00%
- SEK96.63m
- SEK79.37m
- SEK0.52m
Annual balance sheet for Bioextrax AB publ, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2.05 | 8.98 | 27.5 | 13.4 | 17.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.165 | 0.697 | 1.21 | 0.539 | 0.486 |
Prepaid Expenses | |||||
Total Current Assets | 2.44 | 11.4 | 30.4 | 14.8 | 19.2 |
Net Property, Plant And Equipment | 0.597 | 1.22 | 7.49 | 7.76 | 6.82 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3.03 | 12.6 | 37.9 | 22.5 | 29 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.38 | 5.14 | 6.15 | 1.98 | 2.94 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.38 | 5.14 | 6.15 | 1.98 | 2.94 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.65 | 7.5 | 31.8 | 20.5 | 26.1 |
Total Liabilities & Shareholders' Equity | 3.03 | 12.6 | 37.9 | 22.5 | 29 |
Total Common Shares Outstanding |